New Cancer Drug Hope
AstraZeneca has been collaborating with researchers who detected a potential Aurora B inhibitor.
Research
Discovered: a new genetic route to skin cancer
UK - A complex chain of molecular triggers involved in the development of malignant melanoma has been unravelled
The big question
Could dinosaurs hold the key to solving human respiratory problems?
Drug trials
Small and medium-size contract research organisations (CROs) have huge potential. For the last few decades, pharmaceutical companies have increasingly chosen to use medium-size contract research organisations (CROs), or smaller organisations, rather than the larger organisations, due to their enhanced responsiveness and flexibility, that provides good geographic coverage, a broad therapeutic…
Material solutions
Innovative materials and technologies for medical devices are on show by GE Plastics.
MDCT imaging technique to evaluate bone healing
Increased diagnostic possibilities for orthopaedic patients.
Neurobiology
The 2006 Eppendorf and Science prize, the annual international research prize of US$25,000 has been awarded to Doris Tsao PhD, of the USA.
Student's immune defences hit by examination nerves
Researchers found out important links between mental stress and characteristic complex physical inflammation reactions of allergies.
Drug, vaccine and surgery
Obesity is a burgeoning nightmare for everyone involved in healthcare delivery. New treatment possibilities can help to solve this probelm.
Pulmotension
EU multidisciplinary lung research project aims to cure pulmonary hypertension.
Tobacco
Previous studies have shown that tobacco smoking increases the risk ...
The European Institute of Molecular Imaging
The First European Institute of Molecular Imaging (EIMI) was foundet at the Westphalian Wilhelms-University in Muenster, Germany.
An all-out attack on auto-immune disease
The foundation of the AESKU.KIPP Institute, based in Wendelsheim, Germany, presents a platform to initiate and co-ordinate international auto-immunity research projects.
The Spanish National Centre for Cardiovascular Research
The objective of the CNIC is to lead cardiovascular research in Spain and establish itself as a leading international centre.
Here - and the far horizons
Dr Hanns-Joachim Weinmann, Diagnostics and Radiopharmaceuticals, Magnetic Resonance Imaging & X-Ray Research, Schering AG, examines what is feasible and what still lies only at a tantalising distance.
Health technology assessments
An unnecessary rein on medical innovations, or a wise insurance for patients' protection?
Aging and death
A medical failure or biological necessity?
The advent of personalised therapies
12 distinguished researchers and industry representatives presented the latest molecular medicine research at the Molecular Medicine - from Diagnostics to Therapy symposium - one in a series of annual diagnostics seminars organised by the Forum Medicine Technology & Pharmaceutics e.V.
Defying physics
Dr Robert Krieg, Director of MR Molecular Imaging at Siemens Medical Solutions, described, in an interview with Daniela Zimmermann of European Hospital, the limitations of physics and the potential clinical benefits of hybrid technology - and a hitherto hush-hush MRI-PET project
Todays treatments
Dr Christiane Eickelberg, of the University of Giessen Lung Centre (UGLC), outlines the centre's research projects, aims and academic offerings
Pandemic panic sends feathers flying
AIDS, SARS and now H5NI; just a brief beginning or the end? As the virus moves towards Europe, and millions of birds are slaughtered, interest has risen in a Chinese herb, a patent-sharing controversy and drug stockpiling
Bone marrow cells given gene therapy 'shield'
Radiotherapy affects bone marrow cells, lowering production of white blood cells. New research, published in The Journal of Gene Medicine, suggests that pre-treatment with a gene therapy 'shield' could defend healthy bone marrow cells.
Clinical immunology
The fundamental role of inflammation in almost all disease processes has been increasingly recognised over several years.